262 related articles for article (PubMed ID: 18794126)
1. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.
Gong H; Jarzynka MJ; Cole TJ; Lee JH; Wada T; Zhang B; Gao J; Song WC; DeFranco DB; Cheng SY; Xie W
Cancer Res; 2008 Sep; 68(18):7386-93. PubMed ID: 18794126
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
[TBL] [Abstract][Full Text] [Related]
3. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor.
Gong H; Guo P; Zhai Y; Zhou J; Uppal H; Jarzynka MJ; Song WC; Cheng SY; Xie W
Mol Endocrinol; 2007 Aug; 21(8):1781-90. PubMed ID: 17536009
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1.
Wong S; Tan K; Carey KT; Fukushima A; Tiganis T; Cole TJ
Endocrinology; 2010 Jan; 151(1):185-94. PubMed ID: 19966186
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
Uht RM; Anderson CM; Webb P; Kushner PJ
Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers.
Xu Y; Liu X; Guo F; Ning Y; Zhi X; Wang X; Chen S; Yin L; Li X
Cancer Sci; 2012 Jun; 103(6):1000-9. PubMed ID: 22380844
[TBL] [Abstract][Full Text] [Related]
7. Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.
Barbosa ACS; Feng Y; Yu C; Huang M; Xie W
Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):329-339. PubMed ID: 30822161
[TBL] [Abstract][Full Text] [Related]
8. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
9. Estradiol antagonism of glucocorticoid-induced GILZ expression in human uterine epithelial cells and murine uterus.
Whirledge S; Cidlowski JA
Endocrinology; 2013 Jan; 154(1):499-510. PubMed ID: 23183181
[TBL] [Abstract][Full Text] [Related]
10. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
Karmakar S; Jin Y; Nagaich AK
J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
[TBL] [Abstract][Full Text] [Related]
11. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
12. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus.
Sahlin L
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):9-15. PubMed ID: 7577725
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208.
Ji XW; Chen GP; Song Y; Hua M; Wang LJ; Li L; Yuan Y; Wang SY; Zhou TY; Lu W
Acta Pharmacol Sin; 2015 Oct; 36(10):1246-55. PubMed ID: 25937633
[TBL] [Abstract][Full Text] [Related]
15. Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.
Zhang Y; Leung DY; Nordeen SK; Goleva E
J Biol Chem; 2009 Sep; 284(36):24542-52. PubMed ID: 19586900
[TBL] [Abstract][Full Text] [Related]
16. Flightless-I mediates the repression of estrogen receptor α target gene expression by the glucocorticoid receptor in MCF-7 cells.
Yang L; Jeong KW
Endocr J; 2019 Jan; 66(1):65-74. PubMed ID: 30369516
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.
Kinyamu HK; Archer TK
Mol Cell Biol; 2003 Aug; 23(16):5867-81. PubMed ID: 12897156
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells.
Whirledge S; Dixon D; Cidlowski JA
Horm Cancer; 2012 Jun; 3(3):79-92. PubMed ID: 22311344
[TBL] [Abstract][Full Text] [Related]
19. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
20. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
